当前位置: 首页 > 期刊 > 《湖南中医学院学报》 > 202007
编号:13832075
基于聚类分析和因子分析探讨中医治疗视网膜色素变性的用药规律(4)
http://www.100md.com 2020年7月1日 《湖南中医药大学学报》 202007
     [13] 孟 姣,吕振宇,孙传鑫,等.枸杞多糖药理作用研究进展[J].时珍国医国药,2018,29(10):2489-2493.

    [14] ZHOU S F, CHENG J, ZHOU Z W, et al. An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides[J]. Drug Design, Development and Therapy, 2014: 33.

    [15] CHANG R C, SO K F. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. what do we know so far?[J]. Cellular and Molecular Neurobiology, 2008, 28(5): 643-652.

    [16] SONG M K, SALAM N K, ROUFOGALIS B D, et al. Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment[J]. Biochemical Pharmacology, 2011, 82(9): 1209-1218.

    [17] MI X S, FENG Q, LO A C Y, et al. Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension[J]. PLoS One, 2012, 7(10): e45469.

    [18] 胡廣操.张景岳应用熟地的规律及其现代运用研究[D].杭州:浙江中医药大学,2019.

    [19] 董庆海,吴福林,王 涵,等.山药的化学成分和药理作用及临床应用研究进展[J].特产研究,2018,40(4):98-103., http://www.100md.com(李翔 蒋鹏飞 艾慧 彭俊 彭清华)
上一页1 2 3 4